A study of 123I-ioflupan SPECT in normal adult subjects.

A study of 123I-ioflupan SPECT in normal adult subjects. - A study of 123I-ioflupan SPECT in normal adult subjects.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028183

Enrollment

Registered

2017-07-12

Start date

2017-07-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal adult subjects

Interventions

Administration of radiopharmaceutical

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Japanese (2) 30-90 years old (3) UPDRS Part III <5 (4)MOCA-J >=26 (5) Person with the ability to understand and obey the contents of a study (6)The person who can get consent by a document from the person himself

Exclusion criteria

Exclusion criteria: (1) Neurological abnormality (2) Dementia by DSM V (3) Family history for Parkisonism or DLB (4) Contraindication for MRI (5) Taking medicine that influence on accumulation of 123I-ioflupan in the brain (6) REM sleep behavior disorder (7) Allergy for alcohol or iodide (8) Pregnant woman, lactating woman and person with a pregnant possibility (9) Liver dysfunction (10) Unsuitable subject for this study judged by researchers

Design outcomes

Primary

Measure	Time frame
Specific binding of 123I-ioflupan to dopamine transporter in striatum	—

Countries

Japan

Contacts

Public ContactAtsutaka Okizaki

Asahikawa Medical University Department of Radiology

okizaki@asahikawa-med.ac.jp0166-68-2572

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026